Sanofi calls rejection of potential MS blockbuster ‘unexpected’news2026-01-08T20:40:39+00:00January 8th, 2026|Endpoints News|
Illumina hires Eric Green as chief medical officernews2026-01-08T20:30:33+00:00January 8th, 2026|Endpoints News|
Servier launches VC unit focused on European biotech startupsnews2026-01-08T19:24:49+00:00January 8th, 2026|Endpoints News|
FDA staff cuts mostly didn’t impact new drug review timelines, analysis findsnews2026-01-08T19:20:55+00:00January 8th, 2026|Endpoints News|
New Lilly data suggest Zepbound boosted effect of autoimmune drugnews2026-01-08T19:00:03+00:00January 8th, 2026|Endpoints News|
FDA rejects Vanda’s jet lag drug following yearslong dispute news2026-01-08T16:19:50+00:00January 8th, 2026|Endpoints News|
HHS loses bid to suspend court block on 340B rebate pilotnews2026-01-08T15:57:49+00:00January 8th, 2026|Endpoints News|
GSK, Noetik sign cancer deal on AI virtual cell modelsnews2026-01-08T12:00:51+00:00January 8th, 2026|Endpoints News|
Lilly to pay $1.2B for Ventyx and its NLRP3 drugsnews2026-01-07T21:29:45+00:00January 7th, 2026|Endpoints News|
Drugmakers frustrated by vaccine schedule overhaulnews2026-01-06T21:15:01+00:00January 6th, 2026|Endpoints News|
